UNSPSC 41202050: Reovirus serological reagents

In this classification, Reovirus serological reagents are devices used in test to identify specific Reovirus antibodies in serum. US FDA regulates Reovirus serological reagents under 21 CFR 866.3470 and under FDA product code GQB.

UNSPSC 41202050 Reovirus serological reagents (Commodity) encompasses rapid diagnostic testing kits and laboratory supplies used by state and local health departments, correctional agencies, and public health programs for infectious disease screening and surveillance, though recent state and local solicitations under this code reflect broader serological and drug-testing reagent procurement rather than reovirus-specific products. State and local governments buying under this code include state departments of public health (Illinois Department of Public Health), county community supervision and corrections departments (Collin County, Texas), county health services (Collin County Health Care Services), city public health programs (City of Austin), county courts, and specialized state criminal justice agencies (Texas Department of Criminal Justice). The issuing bodies solicited across multiple service models: manufacturer-specific reagent rentals with maintenance bundled as part of lab operations (Illinois IDPH's Hologic and Abbott analyzer agreements); standalone diagnostic supply contracts for standardized test kits (rapid HIV test kits for Austin Public Health); drug testing supplies for offender monitoring programs; and comprehensive lab services encompassing multiple specimen types and test panels. Illinois Department of Public Health has appeared as a repeat buyer for emergency and change-order procurements of serological reagents for state laboratory operations.

Recent activity concentrates in Texas and Illinois. Representative solicitations include the Illinois Department of Public Health's change order (27482DPHOFCDIB53956, IFB, due October 13, 2026) increasing annual NG/CT testing volume from 15,000 to 25,000 tests and kits from 15,000 to 30,000 units under a Hologic Panther NAAT platform reagent rental agreement, with revised contract cost of $900,000 over five years; Collin County Community Supervision and Corrections Department's offender specimen collection and drug testing services RFP (2026-327, due July 23, 2026, estimated $600,000 over two years plus three optional one-year renewals) covering staffing and immunoassay screening with LC/MS/MS or GC/MS confirmation at two collection sites; the City of Austin's rebid for rapid HIV test kits (IFB 9100AAM1023REBID, due September 3, 2026) specifying Abbott Determine HIV 1/2 Ag/Ab Combo Test kits at 375 units annually; and Illinois IDPH's emergency procurement for Abbott HIV/Syphilis reagents (26482DPHFINANB52340, May 5, 2026, $38,079.50) to maintain CLIA certification and uninterrupted testing operations at the Carbondale Laboratory.